Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

72.18
-0.8800-1.20%
Volume:77.64K
Turnover:5.64M
Market Cap:1.66B
PE:15.90
High:74.18
Open:74.09
Low:72.12
Close:73.06
52wk High:99.50
52wk Low:70.15
Shares:22.97M
Float Shares:20.28M
Volume Ratio:0.49
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.78
PE(LYR):21.74

Loading ...

ANI Pharma SVP, CFO Stephen P. Carey Sells 2,850 Shares for $207,480

Reuters
·
Sep 02

ANI Pharmaceuticals Director Henry O. Gosebruch Files Initial Beneficial Ownership Statement (Form 3)

Reuters
·
Aug 28

How Investors Are Reacting To ANI Pharmaceuticals (ANIP) Board Shake-Up And Strategic Expertise Addition

Simply Wall St.
·
Aug 27

ANI Pharma CEO Nikhil Lalwani Disposes of 5,400 Common Shares Worth $401,220

Reuters
·
Aug 27

ANI Pharmaceuticals (ANIP) Gets a Buy from Barclays

TIPRANKS
·
Aug 26

ANI Pharmaceuticals reshapes board to advance rare disease strategy

TIPRANKS
·
Aug 24

A Quiet Monday: What Wall Street Didn't File

FilingAlpha
·
Aug 24

ANI Pharma Appoints Henry Gosebruch to Board of Directors

Reuters
·
Aug 24

ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors

THOMSON REUTERS
·
Aug 24

ANI Pharma General Counsel Meredith Cook Sells 500 Shares for $37,740

Reuters
·
Aug 14

ANI Pharma SVP, Generics Ori Gutwerg Reports Sale of 3,162 Common Shares Worth $243,474

Reuters
·
Aug 12

These Analysts Slash Their Forecasts On ANI Pharmaceuticals After Q2 Results

Benzinga Earnings
·
Aug 10

ANI Pharmaceuticals is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Aug 10

J.P. Morgan Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
Aug 10

ANI Pharmaceuticals price target lowered to $119 from $124 at Guggenheim

TIPRANKS
·
Aug 10

Tonix Q2 Revenue Rises Sharply on Tonmya Launch

Reuters
·
Aug 10

Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth

Reuters
·
Aug 10

Veru Q3 Net Loss Narrows on Lower G&A Expenses

Reuters
·
Aug 10

U.S. Research Roundup-Compass Minerals, Duke Energy, Tesla

Reuters
·
Aug 10

ANI Pharmaceuticals Inc : Canaccord Genuity Cuts Target Price to $90 from $91

THOMSON REUTERS
·
Aug 10